Publicações

Phase Ii and Pharmacogenomics Study of Enzastaurin plus Temozolomide During and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma

AuthID
P-002-J4G

Author(s)

Butowski, N

Chang, SM

Lamborn, KR

Polley, MY

Pieper, R

Costello, JF

Vandenberg, S

Parvataneni, R

Nicole, A

Sneed, PK

Clarke, J

Hsieh, E

Costa, BM

Reis, RM

Hristova Kazmierski, M

Nicol, SJ

Thornton, DE

Prados, MD

Tipo de Documento

Article

Year published

2011

Publicado

in NEURO-ONCOLOGY, ISSN: 1522-8517

Volume: 13, Número: 12, Páginas: 1331-1338 (8)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1093/neuonc/nor130

Pubmed: 21896554

SCOPUS: 2-s2.0-84863011588

Wos: WOS:000297936300009

Source Identifiers

ISSN: 1522-8517

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Phase Ii and Pharmacogenomics Study of Enzastaurin plus Temozolomide During and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Phase Ii and Pharmacogenomics Study of Enzastaurin plus Temozolomide During and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma

Links Úteis

Ajuda